Medpace Q2 2022 Earnings Report
Key Takeaways
Medpace Holdings, Inc. announced financial results for the second quarter ended June 30, 2022, featuring a 26.2% increase in revenue to $351.2 million, net new business awards of $450.6 million, and GAAP net income of $49.4 million, or $1.46 per diluted share.
Revenue increased by 26.2% to $351.2 million compared to the prior-year period.
Net new business awards increased by 16.3% to $450.6 million, resulting in a net book-to-bill ratio of 1.28x.
GAAP net income for the second quarter of 2022 was $49.4 million, or $1.46 per diluted share.
EBITDA increased by 42.0% to $68.1 million, representing an EBITDA margin of 19.4%.
Medpace
Medpace
Forward Guidance
The Company forecasts 2022 revenue in the range of $1.405 billion to $1.435 billion and GAAP net income for full year 2022 is forecasted in the range of $205.0 million to $215.0 million.